Training ADME PK DM | Evaluation of ADMET Drug Properties in Drug Discovery and Development
22 Jan 2013 - 23 Jan 2013 - Sheraton Hotel Brussels Belgium
Mondial Research has joined with strategic partners from the Biotech and
Pharmaceutical Industry to bring together scientific experts to present
and discuss recent advances towards accurately predicting human
toxicities and screening earlier in the drug discovery process.
ADME Optimisation for Drug Design/Discovery
High Content Screening
Biobased Cellular Toxicity Assays
MIP-DILI | IMI
IPS-derived Primary Cultures for Toxicity Assays
In Vitro QT Prolongation Assays with Cardiomyocytes
Biomarker Identification with Toxicogenomics
New Therapeutic Targets in Drug Design/Discovery
Pharmacogenomics and Drug Safety
Regulatory Issues in ADME
A Novel Human Hepatocyte Assay for Accurate Prediction of Severe DILI Drugs
Translational Investigation of Drug Disposition in Children
and much more...
Early Booking - £999 GBP for Conference Only if you book before October 31, 2012
Please contact firstname.lastname@example.org for more info. You can also register online at the link above.